Inactive Instrument

Analyst Reco. Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	05-15	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	04-19	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	04-17	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	04-05	MT
HC Wainwright Raises Fennec Pharmaceuticals Price Target to $18 From $17, Maintains Buy Rating	04-04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	04-03	MT
HC Wainwright Adjusts Price Target on Fennec Pharmaceuticals to $17 From $18, Maintains Buy Rating	23-08-04	MT
Cantor Fitzgerald Adjusts Fennec Pharmaceuticals' Price Target to $16 From $12	23-04-06	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $16 From $17, Maintains Outperform Rating	23-03-30	MT
Wedbush Lowers Fennec Pharmaceuticals' Price Target to $17 From $19, Maintains Outperform Rating	23-01-25	MT
Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $12 From $9	22-11-22	MT
HC Wainwright Adjusts Fennec Pharmaceuticals' Price Target to $18 From $14, Keeps Buy Rating	22-10-20	MT
Maxim Adjusts Fennec Pharmaceuticals' Price Target to $15 from $10, Maintains Buy	22-09-29	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $19 From $11, Maintains Outperform Rating	22-09-26	MT
Capital One Starts Fennec Pharmaceuticals at Overweight With $11 Price Target	22-09-07	MT
Craig-Hallum Assumes Fennec Pharmaceuticals at Buy With $14 Price Target	22-08-08	MT
Wedbush Maintains Outperform, Raises Fennec Pharmaceuticals' TP to US$11	22-05-12	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $11 From $10, Maintains Outperform Rating	22-05-12	MT
Wedbush Maintains Outperform, US$10 TP on Fennec Pharmaceuticals After Q4, Pedmark Update	22-02-28	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $10 From $9, Maintains Outperform Rating	22-02-28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Analyst Reco.

Filters